Contract manufacturing is playing an increasingly important role in the strategic approach companies ranging from big pharma to specialized biotech take in producing products for sale. Among the factors influencing market growth in outsourcing manufacturing are a need to gain better control of costs; a shortage of capacity, expertise or technology in-house; or, as is often the case with startup, specialty and biotech firms, a complete lack of integrated manufacturing capabilities. Because of a growing interest in this market area, SCORR Marketing developed a survey in partnership with Pharmaceutical Outsourcing to gather information from pharmaceutical, biotech, medical device, specialty and generic companies, as well as contract manufacturing organizations (CMOs), to determine trends in contract manufacturing outsourcing. The survey indicated that demand for contract manufacturing services — and competition among CMOs for a share of the market — is increasing. Read more »
Lea Studer is Vice President of Marketing Communications at SCORR Marketing.